Dioxin-induced toxicity on vascular remodeling of the placenta

Biochemical Pharmacology

Volumn 77, Issue 4, 2009, Pages 660-669

  Ishimura, Ryuta ^a   Kawakami, Takashige ^a   Ohsako, Seiichiroh ^a,b   Tohyama, Chiharu ^a,b  

^a NATIONAL INSTITUTE FOR ENVIRONMENTAL STUDIES   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Angiogenesis; Arylhydrocarbon receptor; Hypoxia; Placenta; Vasculogenesis

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; DIOXIN; HYPOXIA INDUCIBLE FACTOR;

ANGIOGENESIS; APOPTOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; FETUS HYPOXIA; HUMAN; NONHUMAN; PLACENTA DEVELOPMENT; PRIORITY JOURNAL; REPRODUCTIVE TOXICITY; REVIEW; SIGNAL TRANSDUCTION; TROPHOBLAST;

ANIMALS; BLOOD VESSELS; ENVIRONMENTAL POLLUTANTS; FEMALE; HUMANS; PLACENTA; PLACENTAL CIRCULATION; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RECEPTORS, ARYL HYDROCARBON; TETRACHLORODIBENZODIOXIN;

EID: 59149096016     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2008.10.030     Document Type: Review

References (83)

1. Hutzinger O., Choudhry G.G., Chittim B.G., and Johnston L.E. Formation of polychlorinated dibenzofurans and dioxins during combustion, electrical equipment fires and PCB incineration. Environ Health Perspect 60 (1985) 3-9
2. Theobald H.M., Kimmel G.L., and Peterson R.E. Developmental and reproductive toxicity of dioxins and related chemicals. In: Schecter A., and Gasiewicz T.A. (Eds). Dioxins and health (2003), Wiley-Interscience, Hoboken, NJ, USA 329-432
3. Antkiewicz D.S., Burns C.G., Carney S.A., Peterson R.E., and Heideman W. Heart malformation is an early response to TCDD in embryonic zebrafish. Toxicol Sci 84 (2005) 368-377
4. Antkiewicz D.S., Peterson R.E., and Heideman W. Blocking expression of AHR2 and ARNT1 in zebrafish larvae protects against cardiac toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Sci 94 (2006) 175-182
5. Walker M.K., and Catron T.F. Characterization of cardiotoxicity induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin and related chemicals during early chick embryo development. Toxicol Appl Pharmacol 167 (2000) 210-221
6. Thackaberry E.A., Nunez B.A., Ivnitski-Steele I.D., Friggins M., and Walker M.K. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on murine heart development: alteration in fetal and postnatal cardiac growth, and postnatal cardiac chronotropy. Toxicol Sci 88 (2005) 242-249
7. Olson J.R., Holscher M.A., and Neal R.A. Toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the golden Syrian hamster. Toxicol Appl Pharmacol 55 (1980) 67-78
8. Guiney P.D., Walker M.K., Spitsbergen J.M., and Peterson R.E. Hemodynamic dysfunction and cytochrome P4501A mRNA expression induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin during embryonic stages of lake trout development. Toxicol Appl Pharmacol 168 (2000) 1-14
9. Mimura J., and Fujii-Kuriyama Y. Functional role of AhR in the expression of toxic effects by TCDD. Biochim Biophys Acta 1619 (2003) 263-268
10. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 6 (2000) 389-395
11. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3 (2003) 721-732
12. Nie M., Blankenship A.L., and Giesy J.P. Interactions between aryl hydrocarbon receptor (AhR) and hypoxia signaling pathways. Environ Toxicol Pharmacol 10 (2001) 17-27
13. Pollenz R.S., Davarinos N.A., and Shearer T.P. Analysis of aryl hydrocarbon receptor-mediated signaling during physiological hypoxia reveals lack of competition for the aryl hydrocarbon nuclear translocator transcription factor. Mol Pharmacol 56 (1999) 1127-1137
14. Ichihara S., Yamada Y., Ichihara G., Nakajima T., Li P., Kondo T., et al. A role for the aryl hydrocarbon receptor in regulation of ischemia-induced angiogenesis. Arterioscler Thromb Vasc Biol 27 (2007) 1297-1304
15. Fritz W.A., Lin T.M., and Peterson R.E. The aryl hydrocarbon receptor (AhR) inhibits vanadate-induced vascular endothelial growth factor (VEGF) production in TRAMP prostates. Carcinogenesis 29 (2008) 1077-1082
16. Ivnitski-Steele I.D., and Walker M.K. Vascular endothelial growth factor rescues 2,3,7,8-tetrachlorodibenzo-p-dioxin inhibition of coronary vasculogenesis. Birth Defects Res A Clin Mol Teratol 67 (2003) 496-503
17. Ivnitski-Steele I.D., Sanchez A., and Walker M.K. 2,3,7,8-Tetrachlorodibenzo-p-dioxin reduces myocardial hypoxia and vascular endothelial growth factor expression during chick embryo development. Birth Defects Res A Clin Mol Teratol 70 (2004) 51-58
18. Ivnitski-Steele I.D., Friggens M., Chavez M., and Walker M.K. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) inhibition of coronary vasculogenesis is mediated, in part, by reduced responsiveness to endogenous angiogenic stimuli, including vascular endothelial growth factor A (VEGF-A). Birth Defects Res A Clin Mol Teratol 73 (2005) 440-446
19. Juan S.H., Lee J.L., Ho P.Y., Lee Y.H., and Lee W.S. Antiproliferative and antiangiogenic effects of 3-methylcholanthrene, an aryl-hydrocarbon receptor agonist, in human umbilical vascular endothelial cells. Eur J Pharmacol 530 (2006) 1-8
20. Michaud S.E., Menard C., Guy L.G., Gennaro G., and Rivard A. Inhibition of hypoxia-induced angiogenesis by cigarette smoke exposure: impairment of the HIF-1alpha/VEGF pathway. FASEB J 17 (2003) 1150-1152
21. Ohtake F., Takeyama K., Matsumoto T., Kitagawa H., Yamamoto Y., Nohara K., et al. Modulation of oestrogen receptor signalling by association with the activated dioxin receptor. Nature 423 (2003) 545-550
22. Ohtake F., Baba A., Takada I., Okada M., Iwasaki K., Miki H., et al. Dioxin receptor is a ligand-dependent E3 ubiquitin ligase. Nature 446 (2007) 562-566
23. Nguyen T.A., Hoivik D., Lee J.E., and Safe S. Interactions of nuclear receptor coactivator/corepressor proteins with the aryl hydrocarbon receptor complex. Arch Biochem Biophys 367 (1999) 250-257
24. Kumar M.B., Tarpey R.W., and Perdew G.H. Differential recruitment of coactivator RIP140 by Ah and estrogen receptors. Absence of a role for LXXLL motifs. J Biol Chem 274 (1999) 22155-22164
25. Marlowe J.L., Knudsen E.S., Schwemberger S., and Puga A. The aryl hydrocarbon receptor displaces p300 from E2F-dependent promoters and represses S phase-specific gene expression. J Biol Chem 279 (2004) 29013-29022
26. Wang S., and Hankinson O. Functional involvement of the Brahma/SWI2-related gene 1 protein in cytochrome P4501A1 transcription mediated by the aryl hydrocarbon receptor complex. J Biol Chem 277 (2002) 11821-11827
27. Beischlag T.V., Wang S., Rose D.W., Torchia J., Reisz-Porszasz S., Muhammad K., et al. Recruitment of the NCoA/SRC-1/p160 family of transcriptional coactivators by the aryl hydrocarbon receptor/aryl hydrocarbon receptor nuclear translocator complex. Mol Cell Biol 22 (2002) 4319-4333
28. Arany Z., Huang L.E., Eckner R., Bhattacharya S., Jiang C., Goldberg M.A., et al. An essential role for p300/CBP in the cellular response to hypoxia. Proc Natl Acad Sci USA 93 (1996) 12969-12973
29. Ebert B.L., and Bunn H.F. Regulation of transcription by hypoxia requires a multiprotein complex that includes hypoxia-inducible factor 1, an adjacent transcription factor, and p300/CREB binding protein. Mol Cell Biol 18 (1998) 4089-4096
30. Kallio P.J., Okamoto K., O'Brien S., Carrero P., Makino Y., Tanaka H., et al. Signal transduction in hypoxic cells: inducible nuclear translocation and recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor-1alpha. EMBO J 17 (1998) 6573-6586
31. Ema M., Hirota K., Mimura J., Abe H., Yodoi J., Sogawa K., et al. Molecular mechanisms of transcription activation by HLF and HIF1alpha in response to hypoxia: their stabilization and redox signal-induced interaction with CBP/p300. EMBO J 18 (1999) 1905-1914
32. Carrero P., Okamoto K., Coumailleau P., O'Brien S., Tanaka H., and Poellinger L. Redox-regulated recruitment of the transcriptional coactivators CREB-binding protein and SRC-1 to hypoxia-inducible factor 1alpha. Mol Cell Biol 20 (2000) 402-415
33. Davies J., and Glasser S.R. Histological and fine structural observations on the placenta of the rat. Acta Anat (Basel) 69 (1968) 542-608
34. Soares M.J. The prolactin and growth hormone families: pregnancy-specific hormones/cytokines at the maternal-fetal interface. Reprod Biol Endocrinol 2 (2004) 51
35. Rossant J., and Cross J.C. Placental development: lessons from mouse mutants. Nat Rev Genet 2 (2001) 538-548
36. Butterstein G.M., and Leathem J.H. Placental growth modification during pregnancy in the rat. Endocrinology 95 (1974) 645-649
37. Winick M., and Noble A. Quantitative changes in ribonucleic acids and protein during normal growth of rat placenta. Nature 212 (1966) 34-35
38. Adelman D.M., Gertsenstein M., Nagy A., Simon M.C., and Maltepe E. Placental cell fates are regulated in vivo by HIF-mediated hypoxia responses. Genes Dev 14 (2000) 3191-3203
39. Kozak K.R., Abbott B., and Hankinson O. ARNT-deficient mice and placental differentiation. Dev Biol 191 (1997) 297-305
40. Maltepe E., Schmidt J.V., Baunoch D., Bradfield C.A., and Simon M.C. Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature 386 (1997) 403-407
41. Cowden Dahl K.D., Fryer B.H., Mack F.A., Compernolle V., Maltepe E., Adelman D.M., et al. Hypoxia-inducible factors 1alpha and 2alpha regulate trophoblast differentiation. Mol Cell Biol 25 (2005) 10479-10491
42. Redman C.W., and Sargent I.L. Latest advances in understanding preeclampsia. Science 308 (2005) 1592-1594
43. Kaufmann P., Black S., and Huppertz B. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod 69 (2003) 1-7
44. Barbieri R.L., and Repeke J.T. Medical disorders during pregnancy. In: Braunwald E., Fauchi A., Kasper D., Hauser S., Longo D., and Jameson J. (Eds). Harrison's Principles Internal Medicine. 16th ed. (2005), McGraw-Hill 32-37
45. Maynard S.E., Min J.Y., Merchan J., Lim K.H., Li J., Mondal S., et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111 (2003) 649-658
46. Cross J.C. The genetics of pre-eclampsia: a feto-placental or maternal problem?. Clin Genet 64 (2003) 96-103
47. Ilekis J.V., Reddy U.M., and Roberts J.M. Preeclampsia-a pressing problem: an executive summary of a National Institute of Child Health and Human Development workshop. Reprod Sci 14 (2007) 508-523
48. Salafia C., and Shiverick K. Cigarette smoking and pregnancy II: vascular effects. Placenta 20 (1999) 273-279
49. Zdravkovic T., Genbacev O., McMaster M.T., and Fisher S.J. The adverse effects of maternal smoking on the human placenta: a review. Placenta 26 Suppl. A (2005) S81-S86
50. Huuskonen P., Storvik M., Reinisalo M., Honkakoski P., Rysa J., Hakkola J., et al. Microarray analysis of the global alterations in the gene expression in the placentas from cigarette-smoking mothers. Clin Pharmacol Ther 83 (2008) 542-550
51. Khera K.S. Extraembryonic tissue changes induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin and 2,3,4,7,8-pentachlorodibenzofuran with a note on direction of maternal blood flow in the labyrinth of C57BL/6N mice. Teratology 45 (1992) 611-627
52. Sparschu G.L., Dunn F.L., and Rowe V.K. Study of the teratogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the rat. Food Cosmet Toxicol 9 (1971) 405-412
53. Murray F.J., Smith F.A., Nitschke K.D., Humiston C.G., Kociba R.J., and Schwetz B.A. Three-generation reproduction study of rats given 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the diet. Toxicol Appl Pharmacol 50 (1979) 241-252
54. Huuskonen H., Unkila M., Pohjanvirta R., and Tuomisto J. Developmental toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the most TCDD-resistant and -susceptible rat strains. Toxicol Appl Pharmacol 124 (1994) 174-180
55. Ishimura R., Kawakami T., Ohsako S., Nohara K., and Tohyama C. Suppressive effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on vascular remodeling that takes place in the normal labyrinth zone of rat placenta during late gestation. Toxicol Sci 91 (2006) 265-274
56. Straszewski-Chavez S.L., Abrahams V.M., and Mor G. The role of apoptosis in the regulation of trophoblast survival and differentiation during pregnancy. Endocr Rev 26 (2005) 877-897
57. Ishimura R., Ohsako S., Kawakami T., Sakaue M., Aoki Y., and Tohyama C. Altered protein profile and possible hypoxia in the placenta of 2,3,7,8-tetrachlorodibenzo-p-dioxin-exposed rats. Toxicol Appl Pharmacol 185 (2002) 197-206
58. Ishimura R., Ohsako S., Miyabara Y., Sakaue M., Kawakami T., Aoki Y., et al. Increased glycogen content and glucose transporter 3 mRNA level in the placenta of Holtzman rats after exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Appl Pharmacol 178 (2002) 161-171
59. Mizutani T., Yoshino M., Satake T., Nakagawa M., Ishimura R., Tohyama C., et al. Identification of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-inducible and -suppressive genes in the rat placenta: induction of interferon-regulated genes with possible inhibitory roles for angiogenesis in the placenta. Endocr J 51 (2004) 569-577
60. Vogel C.F., Li W., Sciullo E., Newman J., Hammock B., Reader J.R., et al. Pathogenesis of aryl hydrocarbon receptor-mediated development of lymphoma is associated with increased cyclooxygenase-2 expression. Am J Pathol 171 (2007) 1538-1548
61. Ray S.S., and Swanson H.I. Dioxin-induced immortalization of normal human keratinocytes and silencing of p53 and p16INK4a. J Biol Chem 279 (2004) 27187-27193
62. Stinchcombe S., Buchmann A., Bock K.W., and Schwarz M. Inhibition of apoptosis during 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated tumour promotion in rat liver. Carcinogenesis 16 (1995) 1271-1275
63. Park S., and Matsumura F. Characterization of anti-apoptotic action of TCDD as a defensive cellular stress response reaction against the cell damaging action of ultra-violet irradiation in an immortalized normal human mammary epithelial cell line, MCF10A. Toxicology 217 (2006) 139-146
64. Davis Jr. J.W., Burdick A.D., Lauer F.T., and Burchiel S.W. The aryl hydrocarbon receptor antagonist, 3′methoxy-4′nitroflavone, attenuates 2,3,7,8-tetrachlorodibenzo-p-dioxin-dependent regulation of growth factor signaling and apoptosis in the MCF-10A cell line. Toxicol Appl Pharmacol 188 (2003) 42-49
65. Paajarvi G., Viluksela M., Pohjanvirta R., Stenius U., and Hogberg J. TCDD activates Mdm2 and attenuates the p53 response to DNA damaging agents. Carcinogenesis 26 (2005) 201-208
66. Huang W., Zhang J., Washington M., Liu J., Parant J.M., Lozano G., et al. Xenobiotic stress induces hepatomegaly and liver tumors via the nuclear receptor constitutive androstane receptor. Mol Endocrinol 19 (2005) 1646-1653
67. Gnarra J.R., Ward J.M., Porter F.D., Wagner J.R., Devor D.E., Grinberg A., et al. Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice. Proc Natl Acad Sci USA 94 (1997) 9102-9107
68. Abbott B.D., and Buckalew A.R. Placental defects in ARNT-knockout conceptus correlate with localized decreases in VEGF-R2, Ang-1, and Tie-2. Dev Dyn 219 (2000) 526-538
69. Chartrel N.C., Clabaut M.T., Boismare F.A., and Schrub J.C. Uteroplacental hemodynamic disturbances in establishment of fetal growth retardation in streptozocin-induced diabetic rats. Diabetes 39 (1990) 743-746
70. Prager R., Abramovici A., Liban E., and Laron Z. Histopathological changes in the placenta of streptozotocin induced diabetic rats. Diabetologia 10 (1974) 89-91
71. Gewolb I.H., Merdian W., Warshaw J.B., and Enders A.C. Fine structural abnormalities of the placenta in diabetic rats. Diabetes 35 (1986) 1254-1261
72. Abramovici A., Sporn J., Prager R., Shaltiel A., Laron Z., and Liban E. Glycogen metabolism in the placenta of streptozotocin diabetic rats. Horm Metab Res 10 (1978) 195-199
73. Gewolb I.H., Barrett C., and Warshaw J.B. Placental growth and glycogen metabolism in streptozotocin diabetic rats. Pediatr Res 17 (1983) 587-591
74. Boileau P., Mrejen C., Girard J., and Hauguel-de Mouzon S. Overexpression of GLUT3 placental glucose transporter in diabetic rats. J Clin Invest 96 (1995) 309-317
75. Hazelhoff Roelfzema W., Roelofsen A.M., and Peereboom-Stegeman J.H. Glycogen content of placenta and of fetal and maternal liver in cadmium-exposed rats. I. A descriptive light microscopic study. Placenta 8 (1987) 27-36
76. Padmanabhan R. Histological and histochemical changes of the placenta in fetal alcohol syndrome due to maternal administration of acute doses of ethanol in the mouse. Drug Alcohol Depend 16 (1985) 229-239
77. Maulik D. Fetal growth restriction: the etiology. Clin Obstet Gynecol 49 (2006) 228-235
78. Kawakami T., Ishimura R., Nohara K., Takeda K., Tohyama C., and Ohsako S. Differential susceptibilities of Holtzman and Sprague-Dawley rats to fetal death and placental dysfunction induced by 2,3,7,8-teterachlorodibenzo-p-dioxin (TCDD) despite the identical primary structure of the aryl hydrocarbon receptor. Toxicol Appl Pharmacol 212 (2006) 224-236
79. Moriguchi T., Motohashi H., Hosoya T., Nakajima O., Takahashi S., Ohsako S., et al. Distinct response to dioxin in an arylhydrocarbon receptor (AHR)-humanized mouse. Proc Natl Acad Sci USA 100 (2003) 5652-5657
80. Tuomisto J.T., Viluksela M., Pohjanvirta R., and Tuomisto J. The AH receptor and a novel gene determine acute toxic responses to TCDD: segregation of the resistant alleles to different rat lines. Toxicol Appl Pharmacol 155 (1999) 71-81
81. Pohjanvirta R., Wong J.M., Li W., Harper P.A., Tuomisto J., and Okey A.B. Point mutation in intron sequence causes altered carboxyl-terminal structure in the aryl hydrocarbon receptor of the most 2,3,7,8-tetrachlorodibenzo-p-dioxin-resistant rat strain. Mol Pharmacol 54 (1998) 86-93
82. Poland A., Glover E., and Kende A.S. Stereospecific, high affinity binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin by hepatic cytosol. Evidence that the binding species is receptor for induction of aryl hydrocarbon hydroxylase. J Biol Chem 251 (1976) 4936-4946
83. Pohjanvirta R., Viluksela M., Tuomisto J.T., Unkila M., Karasinska J., Franc M.A., et al. Physicochemical differences in the AH receptors of the most TCDD-susceptible and the most TCDD-resistant rat strains. Toxicol Appl Pharmacol 155 (1999) 82-95